Positions

Overview

  • Dr. Danila is an Associate Professor of Medicine in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham (UAB). Dr. Danila is an implementation scientist and outcome researcher, passionate about improving the quality, effectiveness and processes/delivery of medical care for patients. Her research program focuses on two main areas: i) the design and evaluation of culturally-adapted and literacy-appropriate health care interventions that improve outcomes for patients with chronic conditions; and ii) the development and implementation of strategies to assist physicians and other health care professionals in engaging in shared decision making and evidence-based clinical practice.

    Dr. Danila is also interested in the redesign of healthcare delivery processes, decreasing healthcare costs and increasing value-based medical care. She has been actively involved as volunteer for the American College of Rheumatology (ACR). She served on the ACR Insurance Subcommittee (ISC) from 2012-2016. She currently serves as a member of the ACR Committee on Quality of Care and as a member of the Alternative Payment Model (APM) Working Group.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Ifnγ induces epigenetic programming of human t-bethi b cells and promotes tlr7/8 and il-21 induced differentiation 2019
    2019 Patient- and Rheumatologist- Perspectives Regarding Challenges to Achieving Optimal Disease Control in Rheumatoid Arthritis. 2019
    2019 Uptake and Clinical Utility of Multibiomarker Disease Activity Testing in the United States. 2019
    2019 Design, analysis, power, and sample size calculation for three-phase interrupted time series analysis in evaluation of health policy interventions 2019
    2019 Genetic influences on susceptibility to rheumatoid arthritis in African-Americans 2019
    2019 Perspectives of Rheumatoid Arthritis Patients on Electronic Communication and Patient-Reported Outcome Data Collection: A Qualitative Study 2019
    2018 Improving drug adherence in osteoporosis: an update on more recent studies 2018
    2018 A Performing Arts Intervention Improves Cognitive Dysfunction in 50 Hospitalized Older Adults. 2018
    2018 Evaluation of a Multimodal, Direct-to-Patient Educational Intervention Targeting Barriers to Osteoporosis Care: A Randomized Clinical Trial 2018
    2018 Use of Scribes for Documentation Assistance in Rheumatology and Endocrinology Clinics: Impact on Clinic Workflow and Patient and Physician Satisfaction 2018
    2018 Advancing the Science and Practice of Medication Adherence 2018
    2018 Age and fecal microbial strain-specific differences in patients with spondyloarthritis 2018
    2018 CUILESS2016: A clinical corpus applying compositional normalization of text mentions 2018
    2018 Routine use of quantitative disease activity measurements among us rheumatologists: Implications for treat-to-target management strategies in rheumatoid arthritis 2018
    2017 Erratum to: Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study (Osteoporosis International, (2017), 28, 8, (2495-2503), 10.1007/s00198-017-4073-5) 2017
    2017 Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study 2017
    2017 Dense genotyping of immune-related regions identifies loci for rheumatoid arthritis risk and damage in African Americans 2017
    2016 A multi-modal intervention for Activating Patients at Risk for Osteoporosis (APROPOS): Rationale, design, and uptake of online study intervention material 2016
    2016 Association of anti-peptidyl arginine deiminase antibodies with radiographic severity of rheumatoid arthritis in African Americans 2016
    2016 Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritis 2016
    2016 Risk of Cardiovascular Outcomes among Psoriasis Patients Treated with Biologics and Other Systemic Agents. 2016
    2015 The role of genetic variants in CRP in radiographic severity in African Americans with early and established rheumatoid arthritis 2015
    2015 Simple regression for correcting δCt bias in RT-qPCR low-density array data normalization 2015
    2015 Brief report: Expression of interferon-γ receptor genes in peripheral blood mononuclear cells is associated with rheumatoid arthritis and its radiographic severity in african americans 2015
    2015 The role of genetic variants in CRP in radiographic severity in African Americans with early and established rheumatoid arthritis 2015
    2014 Gene-body mass index interactions are associated with methotrexate toxicity in rheumatoid arthritis 2014
    2014 HLA-DRB1-associated rheumatoid arthritis risk at multiple levels in African Americans: Hierarchical classification systems, amino acid positions, and residues 2014
    2013 Editorial: Ethnic-specific genetic analyses in rheumatoid arthritis: Incremental gains but valuable contributions to the big picture 2013
    2012 Markers of treatment response to methotrexate in rheumatoid arthritis: Where do we stand? 2012
    2011 The evolution of histopathologic findings in adult still disease 2011
    2010 Measurement of erythrocyte methotrexate polyglutamate levels: Ready for clinical use in rheumatoid arthritis? 2010
    2010 Association of IL4R single-nucleotide polymorphisms with rheumatoid nodules in African Americans with rheumatoid arthritis 2010
    2010 Radiographic severity of rheumatoid arthritis in African Americans: Results from a multicenter observational study 2010
    2010 Genetic variants of STAT4 associated with rheumatoid arthritis in persons of Asian and European ancestry do not replicate in African Americans 2010
    2010 Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: A review of the literature and a case report 2010
    2009 Reply 2009
    2009 Recent advances in personalizing rheumatoid arthritis therapy and management 2009
    2009 Annotating the human genome with Disease Ontology 2009
    2009 Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort 2009
    2009 Renal damage is the most important predictor of mortality within the damage index: Data from LUMINA LXIV, a multiethnic US cohort 2009
    2009 An african ancestry-specific allele of CTLA4 confers protection against rheumatoid arthritis in african americans 2009
    2009 Retraction: an African ancestry-specific allele of CTLA4 confers protection against rheumatoid arthritis in African Americans. 2009
    2009 Understanding personalized medicine in rheumatoid arthritis: A clinician’s guide to the future 2009
    2008 Update on pathogenic mechanisms of systemic necrotizing vasculitis 2008
    2008 Pharmacogenetics of etanercept in rheumatoid arthritis 2008
    2008 Biologics and heart failure in rheumatoid arthritis: Are we any wiser? 2008
    2007 Erratum: Tattoo: Inflicted vasculitis? (Journal of Clinical Rheumatology (2007) 13, (49)) 2007
    2007 Tattoo: inflicted vasculitis? 2007
    2003 The genomic sequence of ectromelia virus, the causative agent of mousepox 2003

    Chapter

    Year Title Altmetric
    2018 Rheumatoid arthritis.  183-199. 2018
    2014 Biology of Normal Joint and Evaluation of the Joint Including CLinical, Imaging, and Pathologic Evaluation.  1912-1919. 2014

    Investigator On

  • INvestigations In Gout, Hyperuricemia, and ComorbidiTies (INSIGHT) Center of Research Translation (CORT)  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2017 - 2022
  • INvestigations In Gout, Hyperuricemia, and ComorbidiTies (INSIGHT) Center of Research Translation (CORT) - Improving Minority Gout Care and Clinical Research Participation in the Southeast  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2017 - 2022
  • Private Grant  awarded by GlaxoSmithKline 2018 - 2021
  • Strengthening Translational Research in Diverse Enrollment (STRIDE)  awarded by UNIVERSITY OF MASSACHUSETTS (WORCESTER) 2016 - 2021
  • DNA Sequencing for Newborn Nurseries in the South  awarded by HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY 2017 - 2020
  • A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease  awarded by Brigham and Women's Hospital 2018 - 2020
  • Private Grant  awarded by Pfizer Inc., U.S. Pharmaceuticals Group 2017 - 2019
  • UAB Multidisciplinary Clinical Research Center (P60)  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2013 - 2019
  • UAB Multidisciplinary Clinical Research Center - Project 2: Facilitating Treat-to-Target Using Novel Health Technology with Decision Support  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2013 - 2019
  • UAB Multidisciplinary Clinical Research Center - Project 3  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2013 - 2019
  • ACE Protocol ARA08: Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis (StopRA)  awarded by University of California, San Francisco 2015 - 2019
  • Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2016 - 2019
  • A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease  awarded by Brigham and Women's Hospital 2018
  • Centers of Research Translation (CoRT)  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2012 - 2017
  • Patient-Centered Outcomes Research Translation Center  awarded by Baylor University 2016 - 2017
  • Private Grant  awarded by Janssen 2016 - 2017
  • Dissection of the ACPA Response in African-Americans with Rheumatoid Arthritis  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2011 - 2016
  • Private Grant  awarded by ABBVIE INC 2016
  • Private Grant  awarded by UCB, INC. 2012 - 2014
  • Private Grant  awarded by Pfizer Inc., U.S. Pharmaceuticals Group 2012 - 2014
  • Education And Training

  • “Carol Davila” University of Medicine and Pharmacy, Internship
  • University of Illinois at Chicago-Advocate Christ Medical Center, Residency 2006
  • UAB Hospital, Postdoctoral Fellowship 2008
  • Full Name

  • Maria Danila